Abeona Therapeutics Inc (ABEO)

CapEx to Revenue

4.21%

Quarterly · Period ending:

ABEO logo

ABEO CapEx to Revenue

Latest reported4.21%
ABEO Quarterly CapEx/Revenue (0.00% → 4.21%)
High-resolution chart · PNG

ABEO capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Abeona Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.2091%
10.7225%
21.2731%
0%
725.25%
0%
0%
0%
0%
0%
0%
0%
0.9143%
0%
36.7647%
0%
0%
29.7688%
108.2667%
0%
0%
0%
1.1%
3.8714%
0%
0%
0%
0%
0%
0%
-512.8759%
96.9573%
1,239.4928%
659.5104%
327.4419%
32.8767%
4.6083%
39.7849%
7.0313%
80.4348%
58.8785%
96.5957%
124.186%
9.4737%
1.773%
3.4884%
0%
0%
0%
0%
0.6173%
0.5291%
0%
0%
1.4911%
0%
0.2899%
0.7008%
7.9051%
0.0961%
11.2583%
14.6667%
0%
0%
0%
0%
1.9231%
0%
0%
4.878%
87.8378%
0%
4.5455%
57.8947%
35.2941%
0%
0%
0%
0%
0%
0%
0%
-4.3682%
0.8439%
6.4257%
6.4516%
14.1304%
93.5135%
39.7059%
300%
62.5%
236.3636%
30.8931%
24.173%
2.3634%
78.022%
64.6388%
125.8621%
927.2727%
2,572.7273%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.